• Precision Medicine AI Agent Platform
          • Precision Medicine AI Agent Platform
          • Security & Compliance
        • Solutions
          • Overview
          • Agent Intelligence (AI)
          • Sample Intelligence (SI)
          • Biomarker Intelligence (BI)
        • Resources
          • News & Insights
          • Webinars & Events
          • FAQs
          • Case Studies
          • Literature
        • About Us
          • Overview
          • Leadership
          • Careers
          • Contact Us
  • Search
  • Menu Menu
Precision Medicine AI Agent Platform Solutions
Log in Book A Demo

American Society for Clinical Oncology 2025 Annual Meeting

May 30 – June 3 (Exhibits May 30 – June 2) | McCormick Place, Chicago IL

Meet QuartzBio’s team of experts at this year’s annual ASCO meeting! See firsthand how AI agents designed for cancer research can accelerate oncology R&D and help teams like yours:

  • Increase your data-to-insights speed by 2X for faster study close
  • Increase R&D output by ≥25%
  • Streamline decision-making with autonomous support

Our team will be stationed in the Precision for Medicine Booth (#11059), use the button below to book a 1:1 meeting:

Schedule time to meet with our team
https://www.quartz.bio/wp-content/uploads/2025/05/Linkedin_1200x1200_ASCO2025_A-1.jpg 1200 1200 QuartzBio Team https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg QuartzBio Team2025-05-12 10:50:312025-05-13 14:15:32Join QuartzBio at ASCO 2025 | Booth #11059
Webinar - Precision Medicine AI Agents - QuartzBio
Webinar - Precision Medicine AI Agents - QuartzBio

Date: 14 May 2025

Time: 12:00 PM EDT | 9:00 AM PDT | 5:00 PM CET

Duration: 30 minutes

Register for the webinar:

What you’ll learn:

R&D teams in biomarker-rich clinical trials are constantly chasing insights around a complex data ecosystem. By the time stakeholders find their data, gain access, ideate on the right analysis and get results, the chance to make impactful decisions may be over. ​

With QuartzBio’s Precision Medicine AI Agent Platform, you can ask questions, get answers, and gain insights at the speed of decision-making.​

Domain-specific AI agents, orchestrated by our Precision Medicine Virtual Assistant, enable operations, translational, and informatics teams to conversationally interact with a connected ecosystem of biomarker, sample, and clinical data. ​

Join Bill Hall as he chats with the Virtual Assistant, conversationally extracting insights in seconds, achieving:​

  • Amplified Operational Efficiency: e.g., “Show me biopsy samples from patients in the 70th percentile of JAK2 expression at baseline”​
  • Autonomous Workflows & Interoperability: e.g., automatically ingesting and harmonizing assay data upon arrival from testing lab​
  • Amplified Translational Research: e.g., ““Compare gene expression profiles for responders vs non-responders at baseline” ​

You’ll learn how QuartzBio’s approach transforms the way precision medicine teams work with 360° intelligence.​

Who should attend:​

  • Translational Scientists​
  • Biomarker Operations and Biospecimen Operations Teams​
  • Data Science and Bioinformatics Teams​
  • R&D Information Technology (IT)​

Register for the Webinar >>

https://www.quartz.bio/wp-content/uploads/2025/04/LinkedIn_MAY-Webinar_1200x1200_Blue-A.jpg 1200 1200 Chandreyee Das https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg Chandreyee Das2025-04-11 13:34:422025-04-29 10:21:43Webinar: Precision Medicine AI Agents Accelerate Data-to-Insights​
SCOPE 2025 QuartzBio Recap
SCOPE 2025 QuartzBio Recap

The promise of precision medicine starts with the sample data value chain.

Sample Data Value Chain: From Site to Result

This value chain was the focus of an exciting session at the 2025 SCOPE Summit for Clinical Operations Executives, where biospecimen operations, biomarker operations, and clinical operations teams shared how sample management practices lead directly to increased quality, speed, and reproducibility of research and development.

This year’s SCOPE conference stood out in a few notable ways:

  • In an industry first, biopharma sponsors joined forces to pursue standardized and interoperable systems, processes, and ecosystems for connecting the sample data value chain.
  • More data scientsts and leaders of IT functions attended the conference than ever, indicating that technology and data is playing and will play a key role for the future of clinical and sample operations.

QuartzBio’s Tobi Guennel, PhD, inspired lively discussion in his presentation, “From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI.”

He explored the opportunities for technology to empower the people and processes across the entire sample data value chain, addressing:

  • The importance of the sample data value chain within the Precision Medicine Value Chain
  • Benefits of connecting data across the entire sample data value chain instead of focusing on individual links of the chain
  • How a platform approach, leveraging a domain-specific Precision Medicine AI Agent Network, enables seamless data ingestion and real-time sample intelligence across the value chain

Watch the recording of our presentation*:

*Video not showing? Please accept cookies or view video here.

https://www.quartz.bio/wp-content/uploads/2025/03/LInkedin_Watch-Video_SCOPE2025_2.jpg 1200 1200 Chandreyee Das https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg Chandreyee Das2025-03-03 16:45:022025-03-03 16:45:04From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI
QuartzBio At the Bio-IT World Conference
QuartzBio At the Bio-IT World Conference

For teams working at the interface between precision medicine and information technology, don’t miss meeting the QuartzBio team at the Bio-IT World Conference and Expo (April 2-4, 2025, Boston, MA).

QuartzBio will be presenting

“The Precision Medicine AI Agent Network: Intelligence at Scale”

4:00 PM, Thursday, April 3, Cloud for AI/ML & Modern Data Science track

We’ll demonstrate how a network of domain-specific AI agents amplifies efforts of translational, informatics, and IT teams, using AI-driven integration of biomarker, sample, and clinical data.

This unified, scalable solution shortens time from data to insights, analytics, and visualizations, accelerating study close and time-to-market.

Then visit booth #614 to explore our Precision Medicine Intelligence Platform, hands-on!

Submit the contact form to book a 1:1 at our booth for a personalized demo experience.

SCHEDULE A DEMO WITH OUR TEAM

https://www.quartz.bio/wp-content/uploads/2025/02/LinkedIn_BioIT2025_AI-Agent-Network_A.jpg 1200 1200 Chandreyee Das https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg Chandreyee Das2025-02-17 21:27:342025-05-09 15:46:10Join QuartzBio at Bio-IT World | Booth #614
QuartzBio webinar conversational AI for biomarker intelligence
QuartzBio webinar conversational AI for biomarker intelligence

On Demand

Duration: 20 minutes

Sign up to watch the webinar on demand

What you’ll learn:

Learn how to use practical, conversational AI to amplify the power of your biomarker-rich clinical programs with QuartzBio’s Precision Medicine AI Agent Platform.

  • Ask a question, get an answer, and gain valuable insights across the precision medicine data ecosystem.
  • Powered by the first ensemble of Precision Medicine Large Language Models (LLMs)
  • Supercharges the day-to-day work of translational researchers, data scientists, and  informatics teams.

Join Bill Hall as he chats with QuartzBio’s Virtual Assistant, conversationally extracting insights in seconds with questions such as:

  • “Which mutations have highest prevalence at baseline?”
  • “Which subjects are in the 70th percentile of JAK2 expression at baseline and have stored, consented, baseline samples?”
  • “What is the correlation of JAK2 and STAT1 expression at baseline across samples?”

You’ll discover QuartzBio’s approach, which employs smart, automated integration of biomarker, sample, and clinical data to create a unified data ecosystem – now amplified with the power of conversational interactions to enable more consumable insights, regardless of your data expertise. 

Who should attend:

Translational Scientists
Data Science and Bioinformatics Teams
R&D Information Technology (IT)

Watch the Webinar >>

https://www.quartz.bio/wp-content/uploads/2024/07/Linkedin_Webinar-SEPT2024_Empowering-PM-with-Conversational-AI_On-Demand-1.jpg 1080 1080 QuartzBio Team https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg QuartzBio Team2024-07-26 19:14:102025-03-26 10:29:38Webinar: Empowering Precision Medicine with Conversational AI — A New Era of Biomarker Intelligence

“Harnessing Insights Across Clinical Trials with the Power of Conversation” — a presentation by Tobi Guennel, Ph.D., head of product development and innovation at QuartzBio 

Watch the recording of the presentation:

Summary:

Discussions were lively at the “Digitization of Clinical Development & Clinical Trials” symposium at last week’s Bio-IT World conference.

Addressing an audience of biotech and pharma IT and data leaders, QuartzBio’s Tobi Guennel gave a provocative presentation on how deploying generative AI can amplify the ability of precision medicine approaches to accelerate drug development.

“It’s great to have a clinical trials-focused session at Bio-IT World, and being able to share success stories, especially about AI, in this landscape,” said Guennel. “We are firm believers that iteration and collaboration can only improve technology and create new paths for innovation.”

Guennel’s narrative centered around QuartzBio’s Precision Medicine AI Agent Platform, powered by AI, which allows precision medicine development teams to extract the most value from clinical trial samples and exploratory biomarker data.

“One benefit of natural language understanding capabilities of conversational AI is that a broad range of user personas, with diverse roles and functions, can interact with and extract insights from a unified, singular data ecosystem of sample and biomarker data.

Teams such as data science, translational research, and biosample or biomarker operations can now interrogate a unified data asset using natural language.”

Considerations for developing a large language model (LLM) ecosystem for precision medicine 

To build a solid GAI framework to enable our sample and biomarker intelligence products, the QuartzBio team asked themselves:

  1. What LLMs are needed to support our domain and the tasks performed through the components of our products?
  2. How can we integrate these models into a scalable GAI workflow to support user stories and workflows without having to re-invent the wheel as we move from use case to use case?
QuartzBio’s Biomarker Intelligence Platform, powered by AI: An ecosystem of domain- and task-specific small LLMs trained by fine-tuning existing foundational models (FMs).
QuartzBio’s Precision Medicine AI Agent Platform, formerly called the Biomarker Intelligence Platform, powered by AI: An ecosystem of domain- and task-specific small LLMs trained by fine-tuning existing foundational models (FMs). LLMs support the data management layer of the platform, the business intelligence layer to support conversational and prescriptive AI insights, and the overarching navigational AI component to enhance user experience and adoption.    

Considerations for developing individual LLMs: 

LLM Development

  • Leverage existing Foundational Models: Start with existing powerful language models that are right-sized.
  • Fine-Tuning: Customize these models for specific domains and tasks.
  • Small LLMs: Create smaller, specialized models for targeted applications for improved cost/accuracy.

GAI Integration

  • Prompt Engineering: Design tailored prompts to guide LLM behavior based on supported tasks.
  • Leverage RAG: Combine LLMs with retrieval mechanisms for enhanced performance.
  • User Agents: Implement user-specific agents to optimize model interactions and leverage live data.

Benefits

  • Precision: Fine-tuned LLMs provide accurate and context-aware responses for specific tasks.
  • Efficiency: Smaller models reduce computational overhead.

Supporting the entire precision medicine lifecycle 

QuartzBio is integrating this GAI framework seamlessly into its Biomarker Intelligence platform to support a broad range of user stories and flows with a suite of SaaS products.

Sponsors are using the platform and products to build an interconnected data asset and, subsequently, draw insights via QuartzBio’s Biomarker Intelligence tools powered by conversational AI.

Sponsors leverage the platform as a force multiplier by creating internal efficiencies. Their teams are free to focus on insight generation rather than data wrangling.

Further, the QuartzBio platform amplifies knowledge by centralizing information and insights and making these easily consumable by a wide range of stakeholders. Ultimately, this increased access to intelligence enables sponsor teams to advance Precision Medicine objectives, such as accelerating patient selection strategies, identifying drug targets, and driving clinical trial efficiency.

Learn more: Watch a demo of QuartzBio’s AI-powered platform

Join the next webinar demonstration of our platform by signing up on our Webinars & Events page! We’ll invite you to our next webinar, and meanwhile you can watch one of our recent demos on demand.

Join QuartzBio at Webinars & Events
https://www.quartz.bio/wp-content/uploads/2024/08/QB_BIOIT_PRES_Tobi_Followup_04242024.jpg 1080 1080 QuartzBio Team https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg QuartzBio Team2024-04-23 15:30:242025-03-26 10:58:06AI-Enabled Biomarker Intelligence — QuartzBio at Bio-IT World 2024

Last week, biomarker intelligence leaders from Boston-area R&D organizations got a firsthand look at the powerful predictive and prescriptive intelligence that will soon infuse QuartzBio’s AI Biomarker Intelligence Platform, after sharing common challenges facing data-rich precision medicine clinical programs. 

Even though our guests represented organizations that varied in size, number of clinical trials, and therapeutic area, they all shared the challenges of disconnected technology and data ecosystems. Over three million data points are generated per clinical trial and over 70% of that data comes from labs. Sponsor organizations are realizing that they are missing opportunities to advance precision medicine if they do not address their data and technology challenges. 

The challenges of disconnected technology and data ecosystems in clinical trials result in delays, fragmented insights, and missed opportunities.

Guest speaker and AI expert, Srivatsan Nagaraja, described the potential of generative AI (GAI) and large language models to overcome these challenges and speed decision-making; not surprisingly, 76% of biopharma companies are investing in AI.

The numbers -- Generative AI overcomes data challenges, speeds decisions.

Srivatsan left the audience with two takeaways:

“Generative AI is not going away – and the journey is as important as the destination.”

The journey, in this context, refers to

  1. How the GAI model is trained and prompted – ideally, by subject matter experts and domain-specific knowledge, iteratively improving the value derived from AI
  2. The quality, structure, and format of the underlying data

The QuartzBio team gave a quick demo of their AI-powered Biomarker Intelligence Platform, showing guests how they could get a 360° look around their sample ecosystem in seconds.

We wrapped up the Biomarker Intelligence Summit with a networking happy hour and hands-on exploration stations. Guests interacted with QuartzBio’s conversational AI Virtual Assistant, experiencing how it could help derive valuable insights quickly and easily.

Have a burning question for our team and/or the QuartzBio AI Virtual Assistant?

Book a demo with us and explore
https://www.quartz.bio/wp-content/uploads/2024/03/QB_Linkedin_Boston-Summit-Recap-2024_1200x1200.jpg 1200 1200 QuartzBio Team https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg QuartzBio Team2024-03-25 14:32:162024-08-16 11:25:28Key Takeaways: Biomarker Intelligence Summit, March 2024 

Key Takeaways from SCOPE Summit for Clinical Operations Executives

Tobi Guennel, PhD, QuartzBio’s Senior Vice President of Product & Chief Architect, energized the Biomarkers & Precision Medicine track at the SCOPE Summit for Clinical Operations Executives by showing how generative AI can address challenges faced biospecimen and biomarker operations teams, as well as clinical and translational teams, when gathering insights on samples across all parts of a complex biomarker data ecosystem.

Sign up to watch the recording:

Sponsor teams need faster answers from disconnected data streams.

Sponsor teams want more clarity. The current chaotic state of biospecimen management hinders speedy decision-making. Because of the influx of specimen (and their associated data) coming from hundreds of varied locations (in just as many varied formats), teams can feel overwhelmed with the sheer volume of information to manage.

“What’s the status of today’s shipments?” “Where is this sample’s location?” “How is Site 53’s sample collection performance?” “What’s the current turnaround time for genetic testing?”

How is the current system holding businesses back? 

Quality data is the foundation of precision medicine but most of this critical data is siloed, inconsistent, and inaccessible. In fact, half of all translational scientists in our industry struggle to access the insights they need to complete their work effectively. Further, many of these scientists report only 60% confidence in the accuracy of this data when manual data entry is considered, and the revenue loss due to data ecosystem challenges is over $31B annually. But, for the companies who can overcome these data and technology ecosystem challenges, the reward is great: these companies are 23x more likely to be profitable than those who cannot.

Generative AI overcomes data challenges

As discussed at the SCOPE Day 1 plenary panel on generative AI, there is now broad awareness of the potential for AI to accelerate drug development. Specifically, we heard how AI is already enabling universal data structuring, harnessing large language models to tackle clinical research tasks, and integrating multimodal data.

Generative AI empowers drug development teams to overcome data and technology ecosystem challenges because it can automate data management tasks and break down data silos, helping businesses gain a holistic view of their operations, and free teams to make more informed decisions, faster. Instead of requiring an extensive understanding of coding and statistical modeling, generative AI now allows users to ask requests in plain language. Ask a question, get an answer.

Generative AI applied to both data management AND business intelligence drives precision medicine at scale

With the Precision Medicine AI Agent Platform, QuartzBio is giving sponsors a smart and scalable platform for deploying generative AI to enhance decision-making throughout the precision medicine R&D lifecycle. This platform is built on a foundation of high-quality data, because insights mean nothing if you don’t first ensure quality data. QuartzBio’s AI-powered data management tools are tailor-made to streamline data ingestion, QC, and mapping for drug development workflows, helping to improve data quality and reduce errors by leveraging automation to surface data issues to stakeholders.

Layered on these data management tools, the platform contains a suite of business intelligence tools that we call biomarker intelligence tools because they were purpose-built to address the challenges in biomarker-guided drug development. These tools are designed by subject matter experts to improve business agility through data exploration, dashboards, analytics, and reporting.

QuartzBio Precision Medicine AI Agent Platform

Leveraging AI across the platform makes our data management and business intelligence tools smarter, easier to use and more efficient to configure. To create a true force amplifier and decision accelerator, we’ve built our Agent Intelligence Solution, powered by our Precision Medicine Virtual Assistant. This assistant transforms the way users interact with our platform to shorten the time from having a question to receiving easily consumable information. The Virtual Assistant is your personal guide through our Precision Medicine AI Agent Platform, allowing you to quickly navigate to the right tool and streamline your data management and business intelligence.

The presentation highlighted four common use cases of the AI Virtual Assistant as applied to QuartzBio’s Sample Intelligence Solution:

  • Sample monitoring for collection, testing, shipping and storage
  • Monitoring vendor performance
  • Tracking clinical trial site performance
  • Monitoring query trends in real time and surfacing root causes
https://www.quartz.bio/wp-content/uploads/2024/02/Tell-me-what-I-dont-know-SCOPE-2024.png 619 619 QuartzBio Team https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg QuartzBio Team2024-02-12 16:41:492025-03-27 12:12:04Tell me what I don’t know: AI-enhanced decisions in biomarker-informed trials

Talk to your data to get fast answers across the entire sample lifecycle​

Duration: 30 minutes

Sign up to watch the webinar on demand:

What you’ll learn:

Every day, you are pressed to make decisions based on chaotic, disconnected flows of biospecimen status and consent information. ​

Learn how conversational AI enables you to talk to your biospecimen data. Ask a question, get an answer, and begin your journey from chaos to insight across the entire biospecimen lifecycle.​

Join Bill Hall for a demo of our Sample Intelligence solution, powered by our Precision Medicine AI Agent Platform and enhanced with the new Agent Intelligence solution:

  • Access, interrogate, and conversationally derive valuable insights from sample data across clinical trials​
  • Proactively surface discrepancies and act on trends as they emerge​
  • Gain insights into vendor and site performance​
  • Get answers in seconds on status of sample shipments, testing, stability and expiration

Bill will be chatting with the QuartzBio Virtual Assistant, the intuitive new guide to the QuartzBio platform!

Who should attend:

  • Biomarker and Biospecimen Operations
  • Clinical Operations
  • Translational Researchers
  • Biosample Management Teams

Watch the Webinar >>

https://www.quartz.bio/wp-content/uploads/2023/12/QuartzBio-Taming-Sample-Chaos-Webinar-Featured-Image.png 559 559 QuartzBio Team https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg QuartzBio Team2023-12-22 15:32:202025-03-26 11:02:56Webinar On Demand: Taming clinical sample chaos with conversational AI
QuartzBio Webinar_Unify Clinical Biomarker Data
QuartzBio Webinar_Unify Clinical Biomarker Data

Explore patient biomarker profiles across assays and vendors with a single solution

Duration: 30 minutes

Sign up to watch the webinar:

What you’ll learn:

Biomarkers, when used to guide clinical programs, could mean the difference between success and failure. 

But exploratory biomarker data can be a headache to manage. Translational and data science teams struggle with disconnected data flows from specialty labs, sponsor data processing pipelines, and clinical data stores.

Join Bill Hall for a webinar demo of the QuartzBio® Biomarker Intelligence (enterprise Biomarker Data Management) solution. 

We’ll show you how to

  • Generate patient profiles to view tumor burden over course of treatment
  • Explore multi-marker views of patient profiles
  • Review ancillary data (e.g. images)
  • Evaluate patient profiles on a cohort level
  • Cross-reference biomarker measures across file types; e.g., compare ctDNA profiles of interest with clinical efficacy biomarkers such as immunohistochemistry

Who should attend: Translational Research teams, Biomarker Operations teams, Clinical/Biomarker Data Science teams, Clinical Development teams, Bioinformatics and Computational Biology teams, Office of the CIO/CTO, Data Management teams

Watch Now >>

https://www.quartz.bio/wp-content/uploads/2023/08/LinkedIn_Webinar_Unify-Clinical-Bi-Data_1200x1200_C.jpg 1200 1200 QuartzBio Team https://www.quartz.bio/wp-content/uploads/2025/03/QuartzBio-Banner-Logo_Blue.svg QuartzBio Team2023-08-11 15:29:582025-04-15 10:43:27Webinar On Demand: Unifying Clinical & Biomarker Data
Page 1 of 41234

Search

QuartzBio Logo_The Precision Medicine Intelligence Company _white
  • Precision Medicine AI Agent Platform
  • Solutions
  • Log In
  • Book a Demo
  • Resources
  • About Us

Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.

QUARTZBIO® and the PRECISION QUARTZBIO® logo are registered trademarks of Precision Medicine Group, LLC in the United States and/or other jurisdictions. All rights reserved.

© 2024. All rights reserved.
Precision Medicine Group, LLC.
Privacy Policy | GDPR

Web Design and Development by RainCastle Communications.

  • Precision Medicine AI Agent Platform
    • Precision Medicine AI Agent Platform
    • Security & Compliance
    • Back
  • Solutions
    • Overview
    • Agent Intelligence (AI)
    • Sample Intelligence (SI)
    • Biomarker Intelligence (BI)
    • Back
  • Resources
    • Resources
    • Webinars & Events
    • FAQs
    • Case Studies
    • Product Literature
    • Back
  • About Us
    • Overview
    • Leadership
    • Careers
    • Contact Us
    • Back
  • Login
  • Book a Demo

Contact App Support



Request Documentation